Research for MS - NOT on MS Meds
March 24, 2016
Find A Cure Panel has some confidential and anonymous online research for patients who have MS who are NOT CURRENTLY
on disease modifying MS treatment.
No personal identifying information is collected. All the researcher will see is a 16 digit respondent id that looks like this: 50010-1234567890.
To qualify for this research, you must:
- Live in the US
- Have been diagnosed with MS
- NOT currently be on a disease modifying MS treatment.
- If you were previously on MS treatment but discontinued it or had never been on MS treatment then you qualify.
- If you are newly diagnosed but have not yet received your prescription, then you will NOT qualify. This research is focused on discontinued treaters and never been treated patients and not newly diagnosed patients.
To participate, please click here
If you have questions or issues with participating, then please email FACP at firstname.lastname@example.org
About the Northern California Chapter of the National Multiple Sclerosis (MS) Society
The Northern California Chapter of the National MS Society was chartered in 1954 and provides comprehensive programs, services and advocacy to assist and empower the more than 84,000 people who are affected by MS annually. The chapter is also a driving force of research for the prevention, treatment and cure of MS and contributes funds to support 350 National MS Society research projects worldwide – including almost $12 million in critical MS research initiatives locally at J. David Gladstone Institutes, UCSF, Stanford, UC Davis and UC Berkeley. The Chapter has offices in San Francisco, Sacramento, Central Valley and Silicon Valley.
About Multiple Sclerosis
Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.